TrialInternational urology and nephrology2010

Neoadjuvant LHRH analog plus estramustine phosphate combined with three-dimensional conformal radiotherapy for intermediate- to high-risk prostate cancer: a randomized study.

Daisaku Hirano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.